# Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.

> **NCT02919644** · PHASE2 · RECRUITING · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 19 (estimated)

## Conditions studied

- Stage IV Colorectal Cancer
- Curative Resection

## Interventions

- **BIOLOGICAL:** autologous dendritic cells loaded with autologous tumour homogenate
- **DRUG:** IL2

## Key facts

- **NCT ID:** NCT02919644
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-12-02
- **Primary completion:** 2026-12
- **Final completion:** 2031-12
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02919644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02919644, "Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02919644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*